El CRAI romandrà tancat del 24 de desembre de 2025 al 6 de gener de 2026. La validació de documents es reprendrà a partir del 7 de gener de 2026.
El CRAI permanecerá cerrado del 24 de diciembre de 2025 al 6 de enero de 2026. La validación de documentos se reanudará a partir del 7 de enero de 2026.
From 2025-12-24 to 2026-01-06, the CRAI remain closed and the documents will be validated from 2026-01-07.
 
Miniatura

Fitxers

655587.pdf (692.83 KB)

Tipus de document

Article

Versió

Versió acceptada

Data de publicació

2015-11-28

Llicència de publicació

cc-by-nc-nd (c) Elsevier B.V., 2015
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/96622

PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

http://dx.doi.org/10.1016/j.colsurfb.2015.11.049

Resum

The growing demand for efficient chemotherapy in many cancers requires novel approaches in target-delivery technologies. Nanomaterials with pH-responsive behavior appear to have potential ability to selectively release the encapsulated molecules by sensing the acidic tumor microenvironment or the low pH found in endosomes. Likewise, polyethylene glycol (PEG)- and poloxamer-modified nanocarriers have been gaining attention regarding their potential to improve the effectiveness of cancer therapy. In this context, DOX-loaded pH-responsive nanoparticles (NPs) modified with PEG or poloxamer were prepared and the effects of these modifiers were evaluated on the overall characteristics of these nanostructures. Chitosan and tripolyphosphate were selected to form NPs by the interaction of oppositely charged compounds. A pH-sensitive lysine-based amphiphile (77KS) was used as a bioactive adjuvant. The strong dependence of 77KS ionization with pH makes this compound an interesting candidate to be used for the design of pH-sensitive devices. The physicochemical characterization of all NPs has been performed, and it was shown that the presence of 77KS clearly promotes a pH-triggered DOX release. Accelerated and continuous release patterns of DOX from CS-NPs under acidic conditions were observed regardless of the presence of PEG or poloxamer. Moreover, photodegradation studies have indicated that the lyophilization of NPs improved DOX stability under UVA radiation. Finally, cytotoxicity experiments have shown the ability of DOX-loaded CS-NPs to kill HeLa tumor cells. Hence, the overall results suggest that these pH-responsive CS-NPs are highly potent delivery systems to target tumor and intracellular environments, rendering them promising DOX carrier systems for cancer therapy.

Matèries

Medicaments antineoplàstics, Quitosan, Nanopartícules, Agents tensioactius, Sistemes d'alliberament de medicaments

Matèries (anglès)

Antineoplastic agents, Chitosan, Nanoparticles, Surface active agents, Drug delivery systems

Citació

Col·leccions

Articles publicats en revistes (Bioquímica i Fisiologia)

Citació

SCHEEREN, Laís e., NOGUEIRA, Daniele r., MACEDO, Letícia b., VINARDELL MARTÍNEZ-HIDALGO, Ma. pilar, MITJANS ARNAL, Montserrat, INFANTE MARTÍNEZ-PARDO, Ma. rosa, ROLIM, Clarice m. b.. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release. _Colloids and Surfaces B-Biointerfaces_. 2015. Vol. 138, núm. 117-127. [consulta: 25 de desembre de 2025]. ISSN: 0927-7765. [Disponible a: https://hdl.handle.net/2445/96622]

Exportar metadades

JSON - METS

Compartir registre